These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7216372)

  • 1. Does vasopressin contribute to salt-induced hypertension in the Dahl strain?
    Matsuguchi H; Schmid PG; Van Orden D; Mark AL
    Hypertension; 1981; 3(2):174-81. PubMed ID: 7216372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of AVP in malignant DOC-salt hypertension: studies using vascular and antidiuretic antagonists.
    Filep J; Frölich JC; Földes-Filep E
    Am J Physiol; 1987 Nov; 253(5 Pt 2):F952-8. PubMed ID: 3688242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dual AngII/AVP receptor gene N119S/C163R variant exhibits sodium-induced dysfunction and cosegregates with salt-sensitive hypertension in the Dahl salt-sensitive hypertensive rat model.
    Ruiz-Opazo N; Lopez LV; Herrera VL
    Mol Med; 2002 Jan; 8(1):24-32. PubMed ID: 11984003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats.
    Hashimoto J; Imai Y; Minami N; Munakata M; Abe K
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):548-54. PubMed ID: 8569214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central mechanisms in DOC-salt hypertensive rats.
    Matsuguchi H; Sharabi FM; O'Connor G; Mark AL; Schmid PG
    Clin Exp Hypertens A; 1982; 4(8):1303-21. PubMed ID: 7116668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of vasopressin as a pressor agent.
    Hofbauer KG; Studer W; Mah SC; Michel JB; Wood JM; Stalder R
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S429-38. PubMed ID: 6206352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic and humoral consequences of chronic infusion of vasopressin in conscious rats.
    Tsuchihashi T; Takata Y; Nakao Y; Tominaga M; Takishita S; Kobayashi K; Abe I; Fujishima M
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):489-95. PubMed ID: 8403529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
    Larivière R; St-Louis J; Schiffrin EL
    J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal baroreflex control of heart rate in prehypertensive and hypertensive Dahl genetically salt-sensitive rats.
    Gordon FJ; Matsuguchi H; Mark AL
    Hypertension; 1981; 3(3 Pt 2):I135-41. PubMed ID: 6114922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of high dietary intakes of sodium or chloride in the Dahl salt-sensitive rat.
    Reddy SR; Kotchen TA
    J Lab Clin Med; 1992 Sep; 120(3):476-82. PubMed ID: 1517694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension-producing factor in serum of hypertensive Dahl salt-sensitive rats.
    Hirata Y; Tobian L; Simon G; Iwai J
    Hypertension; 1984; 6(5):709-16. PubMed ID: 6500676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanisms of salt-induced hypertension in Dahl salt-sensitive rats.
    Bayorh MA; Ogbolu EC; Williams E; Thierry-Palmer M; Sanford G; Emmett N; Harris-Hooker S; Socci RR; Chu TC; Chenault VM
    Physiol Behav; 1998 Dec; 65(3):563-8. PubMed ID: 9877424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension in the recently weaned Dahl salt-sensitive rat despite a diet deficient in sodium chloride.
    Kurtz TW; Morris RC
    Science; 1985 Nov; 230(4727):808-10. PubMed ID: 4059913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of new inbred strains of Dahl-Iwai salt-sensitive and salt-resistant rats.
    Yamazaki K; Katoh H; Yamamoto N; Kurihara K; Iobe H; Sonoda J; Kuwabara M; Kodama M; Kawaguchi A; Funami Y
    Lab Anim Sci; 1994 Oct; 44(5):462-7. PubMed ID: 7844954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.